Data spanning the past 90 days through January 02, 2026 reveals that Amneal Pharmaceuticals's three principal insider shareholders consist of Director Ted C Nark (291.03K shares), Director John Kiely (225.43K shares), Executive Vice President Andrew S Boyer (152.43K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Tushar Bhikhubhai Patel | 48,578,209 | 17 Mar, 2025 | |
| Gautam Patel | 31,993,913 | 18 Jun, 2025 | |
| Dipan Patel | 26,905,073 | 08 Nov, 2023 | |
| Chintu Patel | Co Ceo | 25,617,285 | 05 Mar, 2025 |
| Chirag K. Patel | President & Co Ceo | 22,127,400 | 05 Mar, 2025 |
| Gp A, Llc Tpg | 12,328,767 | 14 Dec, 2022 | |
| Paul M Meister | 784,053 | 08 May, 2025 | |
| Joseph Todisco | Executive Vice President | 327,194 | 10 May, 2022 |
| Jeffrey P. George | 309,795 | 08 May, 2025 | |
| Ted C Nark | 291,029 | 19 Nov, 2025 | |
| Shlomo Yanai | 285,985 | 08 May, 2025 | |
| John Kiely | 225,433 | 28 Aug, 2025 | |
| Emily Peterson Alva | 211,029 | 08 May, 2025 | |
| Andrew S Boyer | Executive Vice President | 152,426 | 22 Aug, 2025 |
| Nikita Shah | Executive Vice President | 146,403 | 14 Nov, 2025 |
| Tasos Konidaris | Executive Vice President & Cfo | 122,152 | 15 Aug, 2025 |
| Deborah M. Autor | 93,660 | 08 May, 2025 | |
| J Kevin Buchi | 40,258 | 08 May, 2025 | |
| Stephen Manzano | Svp And General Counsel | 10,694 | 02 Mar, 2021 |
| Jason B. Daly | Evp And Chief Legal Officer | 10,606 | 13 Aug, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 17 Nov, 2025 | Ted C Nark | Class A Common Stock | D | 50,000 | $11.72 | 291,029 | D | S |
| 12 Nov, 2025 | Nikita Shah | Class A Common Stock | A | 36,331 | $2.75 | 182,734 | D | M |
| 12 Nov, 2025 | Nikita Shah | Class A Common Stock | A | 95,525 | $2.75 | 278,259 | D | M |
| 12 Nov, 2025 | Nikita Shah | Class A Common Stock | D | 131,856 | $11.92 | 146,403 | D | S |
| 27 Aug, 2025 | John Kiely | Class A Common Stock | D | 32,000 | $9.23 | 225,433 | D | S |
| 27 Aug, 2025 | John Kiely | - | - | 225,433 | D | |||
| 22 Aug, 2025 | Nikita Shah | Class A Common Stock | D | 114,492 | $9.66 | 152,743 | D | S |
| 25 Aug, 2025 | Nikita Shah | Class A Common Stock | D | 6,340 | $9.50 | 146,403 | D | S |
| 20 Aug, 2025 | Andrew S Boyer | Class A Common Stock | A | 175,000 | $2.75 | 431,670 | D | M |
| 20 Aug, 2025 | Andrew S Boyer | - | - | 152,426 | D | |||
| 20 Aug, 2025 | Andrew S Boyer | Class A Common Stock | D | 279,244 | $9.38 | 152,426 | D | S |
| 14 Aug, 2025 | Nikita Shah | Class A Common Stock | D | 71,694 | $9.29 | 267,235 | D | S |
| 13 Aug, 2025 | Tasos Konidaris | - | - | 460,517 | D | |||
| 13 Aug, 2025 | Tasos Konidaris | Class A Common Stock | D | 161,365 | $9.22 | 460,517 | D | S |
| 14 Aug, 2025 | Tasos Konidaris | - | - | 341,311 | D | |||
| 14 Aug, 2025 | Tasos Konidaris | Class A Common Stock | D | 119,206 | $9.30 | 341,311 | D | S |
| 15 Aug, 2025 | Tasos Konidaris | - | - | 122,152 | D | |||
| 15 Aug, 2025 | Tasos Konidaris | Class A Common Stock | D | 219,159 | $9.43 | 122,152 | D | S |
| 12 Aug, 2025 | Andrew S Boyer | - | - | 256,670 | D | |||
| 12 Aug, 2025 | Andrew S Boyer | Class A Common Stock | D | 33,436 | $9.05 | 256,670 | D | S |